ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $35,000 | +6.1% | 19,953 | +3.9% | 0.01% | 0.0% |
| Q2 2016 | $33,000 | -13.2% | 19,203 | 0.0% | 0.01% | -16.7% |
| Q1 2016 | $38,000 | +2.7% | 19,203 | 0.0% | 0.01% | -14.3% |
| Q4 2015 | $37,000 | 0.0% | 19,203 | 0.0% | 0.01% | +16.7% |
| Q3 2015 | $37,000 | -58.4% | 19,203 | 0.0% | 0.01% | -53.8% |
| Q2 2015 | $89,000 | +6.0% | 19,203 | 0.0% | 0.01% | +18.2% |
| Q1 2015 | $84,000 | +25.4% | 19,203 | 0.0% | 0.01% | +22.2% |
| Q4 2014 | $67,000 | -14.1% | 19,203 | +2.7% | 0.01% | -18.2% |
| Q3 2014 | $78,000 | -29.1% | 18,700 | 0.0% | 0.01% | -26.7% |
| Q2 2014 | $110,000 | -6.8% | 18,700 | 0.0% | 0.02% | -11.8% |
| Q1 2014 | $118,000 | +8.3% | 18,700 | 0.0% | 0.02% | -5.6% |
| Q4 2013 | $109,000 | – | 18,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |